Testing effectiveness (Phase 2)Study completedNCT01738035
What this trial is testing
The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease
Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 150